Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Overview

The purpose of this survey is to evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.

Bixalomer is administered at initial oral dosage of 500 mg three times a day just before a meal. The dosage can be adjusted based on symptoms and serum phosphorus level.

Conditions

Interventions

Eligibility

Locations (8)

Outcomes